Stone Ridge Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-5,550
Closed -$621K – 777
2019
Q4
$621K Hold
5,550
– – 0.04% 564
2019
Q3
$534K Hold
5,550
– – 0.03% 667
2019
Q2
$475K Hold
5,550
– – 0.03% 734
2019
Q1
$462K Sell
5,550
-2,782
-33% -$202K 0.03% 753
2018
Q4
$535K Buy
8,332
+1,682
+25% +$115K 0.03% 743
2018
Q3
$527K Buy
6,650
+1,100
+20% +$85.1K 0.03% 823
2018
Q2
$406K Hold
5,550
– – 0.02% 895
2018
Q1
$351K Buy
5,550
+300
+6% +$17.9K 0.02% 963
2017
Q4
$268K Buy
+5,250
New +$273K 0.02% 1117

Other funds holding CNMD

Stone Ridge Asset Management's CNMD Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of CONMED (CNMD) in Q1 2020, closing a stake of 5,550 shares — an estimated $621K sold.

Stone Ridge Asset Management first reported a position in CNMD in Q4 2017 and held it in 9 quarters. The position peaked at $621K in Q4 2019. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Stone Ridge Asset Management reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 5,550 CONMED shares in Q1 2020, an estimated $621K.
  • Stone Ridge Asset Management first reported a position in CONMED in Q4 2017 and held it in 9 quarters.
  • Stone Ridge Asset Management's CONMED position peaked at $621K in Q4 2019.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.